Compounds > 1,2-bis(3,5-dioxopiperazin-1-yl)ethane
Page last updated: 2024-08-25

1,2-bis(3,5-dioxopiperazin-1-yl)ethane and Abnormalities, Autosome

1,2-bis(3,5-dioxopiperazin-1-yl)ethane has been researched along with Abnormalities, Autosome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eastmond, DA; Hasegawa, LS; Vuong, MC1

Other Studies

1 other study(ies) available for 1,2-bis(3,5-dioxopiperazin-1-yl)ethane and Abnormalities, Autosome

ArticleYear
A comparative study of the cytotoxic and genotoxic effects of ICRF-154 and bimolane, two catalytic inhibitors of topoisomerase II.
    Mutation research, 2013, Jan-20, Volume: 750, Issue:1-2

    Topics: Antineoplastic Agents; Cell Line; Cell Survival; Chromosome Aberrations; Cytokinesis; Humans; Lymphocytes; Micronucleus Tests; Mutagenicity Tests; Mutagens; Razoxane; Topoisomerase II Inhibitors

2013